Daily Piece: FDA Approval of Nasal Glucagon is Game Changer

FDA’s approval this week of Lilly’s nasal glucagon (Baqsimi) is a true game changer. No more reconstitution!! It comes in portable, compact package containing fixed 3 mg dose. The list price is $280.80 for one pack and $561.60 for two pack. It is approved for treatment of severe hypoglycemia in persons four years of age and older. Baqsimi should be available within pharmacies within a month.

Image result for nasal glucagon baqsimi lilly

https://investor.lilly.com/news-releases/news-release-details/baqsimitm-glucagon-nasal-powder-3-mg-first-and-only-nasally?utm_source=Closer+Look+Subscribers+2018&utm_campaign=3fc7210552-2019-07-24_Lilly_Nasal_Glucagon07_24_2019&utm_medium=email&utm_term=0_c55d924bf1-3fc7210552-412262441

This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#nasal #glucagon #severe #hypoglycemia #Lilly

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.

Leave a Reply

Your email address will not be published. Required fields are marked *